Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel‐based chemotherapy

Brain metastases in patients with epithelial ovarian cancer (EOC) have an estimated incidence of 0.3–1.9% and are isolated in up to 50% of these patients. The risk factors and the prognostic significance of isolated central nervous system (CNS) relapse in patients with EOC who received primary treat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of gynecological cancer 2006-05, Vol.16 (3), p.994-999
Hauptverfasser:	KASTRITIS, E., EFSTATHIOU, E., GIKA, D., BOZAS, G., KOUTSOUKOU, V., PAPADIMITRIOU, C., PISSAKAS, G., DIMOPOULOS, M.A., BAMIAS, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use brain metastases Brain Neoplasms - drug therapy Brain Neoplasms - radiotherapy Brain Neoplasms - secondary Carboplatin - administration & dosage Cisplatin - administration & dosage Combined Modality Therapy Echoencephalography Female Humans Middle Aged Neoplasm Staging Neoplasms, Glandular and Epithelial - secondary ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology paclitaxel Paclitaxel - administration & dosage Paclitaxel - therapeutic use platinum Recurrence Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!